Document 0201 DOCN M9610201 TI Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. DT 9601 AU Cosentino GP; Venkatesan S; Serluca FC; Green SR; Mathews MB; Sonenberg N; Department of Biochemistry, McGill University, Montreal, QC; Canada. SO Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9445-9. Unique Identifier : AIDSLINE MED/96003795 AB The yeast two-hybrid system and far-Western protein blot analysis were used to demonstrate dimerization of human double-stranded RNA (dsRNA)-dependent protein kinase (PKR) in vivo and in vitro. A catalytically inactive mutant of PKR with a single amino acid substitution (K296R) was found to dimerize in vivo, and a mutant with a deletion of the catalytic domain of PKR retained the ability to dimerize. In contrast, deletion of the two dsRNA-binding motifs in the N-terminal regulatory domain of PKR abolished dimerization. In vitro dimerization of the dsRNA-binding domain required the presence of dsRNA. These results suggest that the binding of dsRNA by PKR is necessary for dimerization. The mammalian dsRNA-binding protein TRBP, originally identified on the basis of its ability to bind the transactivation region (TAR) of human immunodeficiency virus RNA, also dimerized with itself and with PKR in the yeast assay. Taken together, these results suggest that complexes consisting of different combinations of dsRNA-binding proteins may exist in vivo. Such complexes could mediate differential effects on gene expression and control of cell growth. DE Amino Acid Sequence Human Molecular Sequence Data Protein Binding Protein Conformation Protein-Serine-Threonine Kinases/GENETICS/*METABOLISM Recombinant Fusion Proteins/METABOLISM RNA-Binding Proteins/GENETICS/*METABOLISM Sequence Deletion Structure-Activity Relationship Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Trans-Activation (Genetics) JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).